It remains to be investigated whether ATP11B exerts its therapeutic effects on pathological LDs primarily through signaling pathways associated with ApoE4 and TREM2, ultimately improving cognitive impairment and AD pathology in AD mice. Here, ATP11B is linked to Cognitive impairment.